Inactive Instrument

Predictive Technology Group, Inc. Share Price Other OTC

Equities

PRED

US74039H1023

Biotechnology & Medical Research

Sales 2019 43.49M 3.47B Sales 2020 24.44M 1.95B Capitalization 126M 10.04B
Net income 2019 -15M -1.2B Net income 2020 -85M -6.79B EV / Sales 2019 28.9 x
Net Debt 2019 798K 63.69M Net Debt 2020 7.51M 600M EV / Sales 2020 5.45 x
P/E ratio 2019
-79.8 x
P/E ratio 2020
-1.42 x
Employees -
Yield 2019 *
-
Yield 2020
-
Free-Float 100%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 55 29/03/15
Corporate Officer/Principal - -
Corporate Officer/Principal - 03/06/19
Members of the board TitleAgeSince
Chief Executive Officer 55 29/03/15
Chairman 69 29/10/18
Director/Board Member 67 18/03/19
More insiders
Predictive Technology Group, Inc. is a life science company. The Company, through its subsidiaries, is focused on specific points of the care continuum, including detection, prevention and treatment. Predictive Analytics, Predictive Laboratories, and Predictive Biotech each bring critical solutions to personalized patient care by leveraging its research, genomics, genetic library and expertise in developing bioscience solutions. Predictive Analytics is the repository for its genetic library. Predictive Biotech provides regenerative medicine. Its products are derived from tissue sources rich in properties that support the body’s natural ability to heal itself. All products are safely, ethically and minimally processed to deliver allografts that preserve the naturally occurring characteristics and factors of the donor tissue. Its research and use of processing methods has propelled its placental-derived and Wharton’s Jelly umbilical cord-derived products to new heights.
More about the company